Marquis Who's Who Honors Shawn Patrick O'Brien for Expertise in Pharmaceuticals and Biotechnology
Press Release January 18, 2025
Shawn Patrick O'Brien is noted for his distinguished tenure in the pharmaceutical industry with Mayne Pharma
img img

RALEIGH, NC, January 18, 2025 /24-7PressRelease/ -- Shawn Patrick O'Brien has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mr. O'Brien is a seasoned professional in the pharmaceutical industry with over four decades of experience. Since 2022, he has been the chief executive officer and managing director at Mayne Pharma. Leading his team with a focus on supply chain management, commercialization, and product development, Mr. O'Brien's ability to see value where others do not has been a hallmark of his career. Based in Raleigh, North Carolina, Mayne Pharma is recognized as an ASX-listed specialty pharmaceutical Company specializing in commercializing novel and generic pharmaceuticals.

Before the launch of Mayne Pharma, Mr. O'Brien held several key positions across the pharmaceutical and biotechnology sectors. He was the president and chief executive officer at Cipher Pharmaceuticals Inc., a Canadian pharmaceutical manufacturing company. He also founded and served as the president, chief executive officer, and board director at Altherx Inc. in Pennsylvania and in the same capacity at Profectus BioSciences Inc. in Baltimore and Solstice Neurosciences in San Francisco. Among other noteworthy roles, Mr. O'Brien was affiliated with AstraZeneca, where he progressed from an executive director to the vice president of the respiratory and inflammation business unit and as the vice president of commercial operations for emerging brands.

Apart from his primary career initiatives, Mr. O'Brien has been heavily engaged in board positions. He has been active as the chair of Key BioPharma Partners since 2008, as an advisory board member for the Greater Philadephia Life Sciences Congress since 2009, and as chair of SFA Therapeutics since 2022.

Mr. O'Brien's career is marked by several significant achievements. Most notably, he was instrumental in launching Seroquel during his tenure with AstraZeneca, elevating the company's revenue from $110 million to $5.6 billion and surpassing two competitor products.

In preparation for his career, Mr. O'Brien earned a Bachelor of Science in microbiology and immunology from Western University in 1982. Beyond his professional endeavors, he is actively involved in professional organizations, such as Life Sciences Pennsylvania. Mr. O'Brien has also been active civically, serving on the advisory board for the Philadelphia Life Sciences convention bureau, as a judge for the Entrepreneur of the Year Program, and as a co-chair and advisory board member of the Schoemaker Classic for Melmark.

Mr. O'Brien's contributions have been honored with several internal awards from AstraZeneca and recognition as the Entrepreneur of the Year by Philadelphia Life Sciences in 2007. Eager for the future of his career in the industry, he plans to continue contributing to the pharmaceutical sector by maintaining his involvement in various board positions and developing effective medications.

# # #

Contact Information

-- --

Marquis Who's Who Ventures LLC

Uniondale, NY

USA

Telephone: 844-394-6946

Email: Email Us Here

Website: Visit Our Website

Follow Us: fb in x